|Bid||7.45 x 0|
|Ask||7.82 x 0|
|Day's Range||7.30 - 7.78|
|52 Week Range||6.18 - 15.91|
|Beta (5Y Monthly)||1.73|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 07, 2022 - Nov 11, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.19|
Subscribe to Yahoo Finance Plus to view Fair Value for CURA.CN
The U.S. market for cannabis is staggering, according to Tilray CEO Irwin Simon — even as it awaits a green light from Congress.
Owen Bennett of Jefferies cuts estimates on major cannabis names as the economic slowdown and oversupply in some markets bite into projections.
The cannabis companies are being hurt as economy-minded buyers turn to cheaper marijuana while many states--and the federal government--have yet to legalize the drug.